XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-In
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income
Beginning Balance (in shares) at Dec. 31, 2021   198,084,000      
Beginning balance at Dec. 31, 2021 $ 197,551 $ 198 $ 947,160 $ (748,012) $ (1,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   202,000      
Issuance of common stock upon exercise of stock options 225   225    
Issuance of common stock upon vesting of restricted stock awards (in shares)   392,000      
Stock-based compensation 22,346   22,346    
Repurchased common stock (in shares)   (79,000)      
Repurchased common stock (1,102)     (1,102)  
Other comprehensive income (loss) 1,440       1,440
Net income (loss) (25,753)     (25,753)  
Ending Balance (in shares) at Mar. 31, 2022   198,599,000      
Ending balance at Mar. 31, 2022 194,707 $ 198 969,731 (774,867) (355)
Beginning Balance (in shares) at Dec. 31, 2021   198,084,000      
Beginning balance at Dec. 31, 2021 197,551 $ 198 947,160 (748,012) (1,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) 6,293        
Net income (loss) $ (50,477)        
Ending Balance (in shares) at Sep. 30, 2022 193,848,000 193,848,000      
Ending balance at Sep. 30, 2022 $ 157,245 $ 193 1,015,068 (862,514) 4,498
Beginning Balance (in shares) at Mar. 31, 2022   198,599,000      
Beginning balance at Mar. 31, 2022 194,707 $ 198 969,731 (774,867) (355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   174,000      
Issuance of common stock upon exercise of stock options 1,262   1,262    
Issuance of common stock upon vesting of restricted stock awards (in shares)   268,000      
Issuance of common stock upon vesting of restricted stock awards 0 $ 1 (1)    
Shares surrendered for settlement of minimum statutory tax withholdings (in shares)   (1,000)      
Shares surrendered for settlement of minimum statutory tax withholdings (30)   (30)    
Stock-based compensation 23,596   23,596    
Repurchased common stock (in shares)   (2,961,000)      
Repurchased common stock (38,053) $ (3)   (38,050)  
Other comprehensive income (loss) 2,209       2,209
Net income (loss) (12,743)     (12,743)  
Ending Balance (in shares) at Jun. 30, 2022   196,079,000      
Ending balance at Jun. 30, 2022 170,948 $ 196 994,558 (825,660) 1,854
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   46,000      
Issuance of common stock upon exercise of stock options 195   195    
Issuance of common stock upon vesting of restricted stock awards (in shares)   350,000      
Issuance of common stock upon vesting of restricted stock awards 0        
Shares surrendered for settlement of minimum statutory tax withholdings (in shares)   (2,000)      
Shares surrendered for settlement of minimum statutory tax withholdings (11)   (11)    
Stock-based compensation 20,326   20,326    
Repurchased common stock (in shares)   (2,625,000)      
Repurchased common stock (24,876) $ (3)   (24,873)  
Other comprehensive income (loss) 2,644       2,644
Net income (loss) $ (11,981)     (11,981)  
Ending Balance (in shares) at Sep. 30, 2022 193,848,000 193,848,000      
Ending balance at Sep. 30, 2022 $ 157,245 $ 193 1,015,068 (862,514) 4,498
Beginning Balance (in shares) at Dec. 31, 2022 190,822,000 190,822,000      
Beginning balance at Dec. 31, 2022 $ 142,375 $ 190 1,032,550 (891,862) 1,497
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   28,000      
Issuance of common stock upon exercise of stock options 22   22    
Issuance of common stock upon vesting of restricted stock awards (in shares)   1,164,000      
Issuance of common stock upon vesting of restricted stock awards 0 $ 1 (1)    
Stock-based compensation 17,378   17,378    
Repurchased common stock (in shares)   (771,000)      
Repurchased common stock (6,768) $ (1)   (6,767)  
Other comprehensive income (loss) (631)       (631)
Net income (loss) (2,358)     (2,358)  
Ending Balance (in shares) at Mar. 31, 2023   191,244,000      
Ending balance at Mar. 31, 2023 $ 150,017 $ 190 1,049,948 (900,987) 866
Beginning Balance (in shares) at Dec. 31, 2022 190,822,000 190,822,000      
Beginning balance at Dec. 31, 2022 $ 142,375 $ 190 1,032,550 (891,862) 1,497
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchased common stock (in shares) (5,867,835)        
Other comprehensive income (loss) $ (14)        
Net income (loss) $ 6,571        
Ending Balance (in shares) at Sep. 30, 2023 187,776,000 187,776,000      
Ending balance at Sep. 30, 2023 $ 147,342 $ 187 1,086,222 (940,550) 1,483
Beginning Balance (in shares) at Mar. 31, 2023   191,244,000      
Beginning balance at Mar. 31, 2023 150,017 $ 190 1,049,948 (900,987) 866
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   362,000      
Issuance of common stock upon exercise of stock options 2,951   2,951    
Issuance of common stock upon vesting of restricted stock awards (in shares)   661,000      
Issuance of common stock upon vesting of restricted stock awards 0 $ 1 (1)    
Shares surrendered for settlement of minimum statutory tax withholdings (in shares)   (232,000)      
Shares surrendered for settlement of minimum statutory tax withholdings (2,469)   (2,469)    
Stock-based compensation 20,031   20,031    
Repurchased common stock (in shares)   (378,000)      
Repurchased common stock (3,041)     (3,041)  
Other comprehensive income (loss) (536)       (536)
Net income (loss) 1,395     1,395  
Ending Balance (in shares) at Jun. 30, 2023   191,657,000      
Ending balance at Jun. 30, 2023 168,349 $ 191 1,070,461 (902,633) 330
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   326,000      
Issuance of common stock upon exercise of stock options 3,011   3,011    
Issuance of common stock upon vesting of restricted stock awards (in shares)   824,000      
Issuance of common stock upon vesting of restricted stock awards 0 $ 1 (1)    
Shares surrendered for settlement of minimum statutory tax withholdings (in shares)   (312,000)      
Shares surrendered for settlement of minimum statutory tax withholdings (3,884)   (3,884)    
Stock-based compensation $ 16,635   16,635    
Repurchased common stock (in shares) (4,718,755) (4,719,000)      
Repurchased common stock $ (45,164) $ 5   (45,159)  
Stock repurchase excise tax (292)     (292)  
Other comprehensive income (loss) 1,153       1,153
Net income (loss) $ 7,534     7,534  
Ending Balance (in shares) at Sep. 30, 2023 187,776,000 187,776,000      
Ending balance at Sep. 30, 2023 $ 147,342 $ 187 $ 1,086,222 $ (940,550) $ 1,483